Chemo-Pharma [CPL] vs AksharChem India [AKSHARCHEM] Detailed Stock Comparison

Chemo-Pharma Laboratories Inc.

BSE
Loading...

AksharChem India Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Chemo-Pharma Laboratories Inc. wins in 11 metrics, AksharChem India Ltd. wins in 7 metrics, with 0 ties. Chemo-Pharma Laboratories Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Chemo-Pharma Laboratories Inc. AksharChem India Ltd. Better
P/E Ratio (TTM) 13.22 94.70 Chemo-Pharma Laboratories Inc.
Price-to-Book Ratio 2.69 0.59 AksharChem India Ltd.
Debt-to-Equity Ratio 48.02 28.44 AksharChem India Ltd.
PEG Ratio 0.42 -0.19 Chemo-Pharma Laboratories Inc.
EV/EBITDA 13.60 14.04 Chemo-Pharma Laboratories Inc.
Profit Margin (TTM) 6.53% -1.09% Chemo-Pharma Laboratories Inc.
Operating Margin (TTM) 11.52% -1.57% Chemo-Pharma Laboratories Inc.
EBITDA Margin (TTM) 11.52% N/A N/A
Return on Equity 20.97% 1.81% Chemo-Pharma Laboratories Inc.
Return on Assets (TTM) 11.26% 1.15% Chemo-Pharma Laboratories Inc.
Free Cash Flow (TTM) $41.66M $-93.80M Chemo-Pharma Laboratories Inc.
Dividend Yield N/A 0.20% N/A
1-Year Return -5.34% -17.00% Chemo-Pharma Laboratories Inc.
Price-to-Sales Ratio (TTM) 1.31 0.44 AksharChem India Ltd.
Enterprise Value $5.40B $2.28B Chemo-Pharma Laboratories Inc.
EV/Revenue Ratio 1.52 0.64 AksharChem India Ltd.
Gross Profit Margin (TTM) 24.93% 42.92% AksharChem India Ltd.
Revenue per Share (TTM) $62 $445 AksharChem India Ltd.
Earnings per Share (Diluted) $5.81 $-4.82 Chemo-Pharma Laboratories Inc.
Beta (Stock Volatility) 0.28 0.28 AksharChem India Ltd.

Chemo-Pharma Laboratories Inc. vs AksharChem India Ltd. Stock Performance Analysis

Loading Price Chart...

CPL
AKSHARCHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Chemo-Pharma Laboratories Inc.0.43%-0.20%-9.72%10.04%-11.06%-12.31%
AksharChem India Ltd.-0.54%-2.68%3.71%21.29%-17.19%-15.46%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Chemo-Pharma Laboratories Inc.-5.34%232.23%82.57%325.71%1,271.09%1,271.09%
AksharChem India Ltd.-17.00%-16.98%-42.43%-71.53%-71.53%-71.53%

Performance & Financial Health Analysis: Chemo-Pharma Laboratories Inc. vs AksharChem India Ltd.

MetricCPLAKSHARCHEM
Market Information
Market Cap i₹4.62B₹1.56B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i97,7004,291
90 Day Avg. Volume i68,66111,446
Last Close₹70.50₹205.87
52 Week Range₹52.67 - ₹87.75₹141.30 - ₹330.80
% from 52W High-19.66%-37.77%
All-Time High₹128.00 (Jan 06, 2025)₹945.00 (May 15, 2017)
% from All-Time High-44.92%-78.21%
Growth Metrics
Quarterly Revenue Growth0.40%-0.11%
Quarterly Earnings Growth0.41%-0.11%
Financial Health
Profit Margin (TTM) i0.07%-0.01%
Operating Margin (TTM) i0.12%-0.02%
Return on Equity (TTM) i0.21%0.02%
Debt to Equity (MRQ) i48.0228.44
Cash & Liquidity
Book Value per Share (MRQ)₹28.58₹325.51
Cash per Share (MRQ)₹0.05₹2.33
Operating Cash Flow (TTM) i₹277.99M₹66.50M
Levered Free Cash Flow (TTM) i₹313.23M₹47.70M
Dividends
Last 12-Month Dividend Yield iN/A0.20%
Last 12-Month Dividend i₹0.00₹0.50

Valuation & Enterprise Metrics Analysis: Chemo-Pharma Laboratories Inc. vs AksharChem India Ltd.

MetricCPL (Apr 26, 2026)AKSHARCHEM (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i13.2294.70
Forward P/E iN/AN/A
PEG Ratio i0.42-0.19
Price to Sales (TTM) i1.310.44
Price to Book (MRQ) i2.690.59
Market Capitalization
Market Capitalization i₹4.62B₹1.56B
Enterprise Value i₹5.40B₹2.28B
Enterprise Value Metrics
Enterprise to Revenue i1.520.64
Enterprise to EBITDA i13.6014.04
Risk & Other Metrics
Beta i0.280.28
Book Value per Share (MRQ) i₹28.58₹325.51

Financial Statements Comparison: Chemo-Pharma Laboratories Inc. vs AksharChem India Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCPL (2025)AKSHARCHEM (2025)
Revenue/Sales i2.85B3.46B
Cost of Goods Sold i2.07B2.08B
COGS % of Revenue i72.6%60.1%
Gross Profit i778.98M1.38B
Gross Margin i27.4%39.9%
Research & Development iN/AN/A
Operating Income (EBIT) i300.69M108.32M
Operating Margin i10.6%3.1%
EBITDA i353.29M244.08M
EBITDA Margin i12.4%7.0%
Pre-Tax Income i392.47M58.26M
Pre-Tax Income % of Revenue i13.8%1.7%
Income Tax i79.24M10.56M
Income Tax % of Revenue i2.8%0.3%
Net Income (Profit) i313.23M47.70M
Profit Margin i11.0%1.4%

Balance Sheet & Liquidity Metrics

MetricCPL (2025)AKSHARCHEM (2025)
Cash & Equivalents i12.05M1.44M
Total Current Assets i2.51B1.34B
Total Current Assets % of Revenue i88.1%38.8%
Total Current Liabilities i1.17B1.15B
Total Current Liabilities % of Revenue i41.2%33.3%
Long-Term Debt i109.50M133.16M
Long-Term Debt % of Revenue i3.8%3.8%
Total Shareholders Equity i1.49B2.64B
Retained Earnings i1.08B1.70B
Retained Earnings % of Revenue i37.9%49.0%
Property, Plant & Equipment i48.61M2.31B

Cash Flow Statement Comparison

MetricCPL (2025)AKSHARCHEM (2025)
Operating Cash Flow i277.99M66.50M
Operating Cash Flow % of Revenue i9.8%1.9%
Capital Expenditures i-47.82M-442.03M
Free Cash Flow i41.66M-93.80M
FCF Margin i1.5%-2.7%
Debt Repayment i-359.80MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCPLAKSHARCHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i60.18M8.03M
Float Shares i17.41M2.30M
% Held by Insiders i69.98%71.19%
% Held by Institutions i0.00%0.00%
% Held by Public i30.02%28.81%

Dividend Analysis & Yield Comparison: Chemo-Pharma Laboratories Inc. vs AksharChem India Ltd.

MetricCPLAKSHARCHEM
Last 12-Month Dividend i₹0.00₹0.50
Last 12-Month Dividend Yield iN/A0.20%
3-Year Avg Annual Dividend i₹0.00₹0.50
3-Year Avg Dividend Yield iN/A0.15%
3-Year Total Dividends i₹0.00₹1.50
Ex-Dividend DateN/ASep 23, 2024